Health in Maldives 1,061 indicators covering health for Maldives. IndicatorLatest Year10-yr change Rank Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 25.5% 2024 down 16.1% 42nd Liver cancer death rate 4.03 2021 up 20.8% 61st Number of female leprosy new cases 0 2024 down 100.0% 102nd National smoking ban: NUMBER OF PLACES SMOKE-FREE 5 2022 unchanged 96th Contraceptive prevalence, any modern method 14.9% 2017 down 44.8% 106th Number of prevalent tuberculosis cases 200 2014 down 13.0% 165th Number of new G2D leprosy cases 0 2024 — 86th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 — 86th Proportion of total government spending on essential services, health 2.9% 2011 down 71.8% 110th Pancreatic cancer death rate 2.47 2021 up 54.1% 95th Brain and nervous system cancer death rate 1.26 2021 up 136.8% 101st Inflation-adjusted prices for most sold brand of cigarettes: Prices 13.28 2022 up 129.8% 18th Taxes as a % of price: total tax 29.9% 2022 down 38.5% 155th Taxes as a % of price: value added tax 5.7% 2022 — 154th Taxes as a % of price: ad valorem excise 0.0% 2022 — 106th Taxes as a % of price: specific excise 0.0% 2022 — 134th Taxes as a % of price: import duties 24.2% 2022 down 50.2% 4th Taxes as a % of price: other taxes 0.0% 2022 — 56th Inflation-adjusted prices for most sold brand of cigarettes: Price in 100 2022 up 133.6% 74th Prevalence of severe wasting, weight for height 2.0% 2017 down 25.9% 17th Physical activity policies for activie societies 20 2023 up 100.0% 2nd Physical activity policies focused on active systems 10 2023 down 50.0% 99th Death rate from poisonings 0.1 2021 unchanged 158th Mortality rate attributed to cardiovascular disease, cancer, diabetes 9 % 2021 down 56.5% 158th Mortality rate attributed to unintentional poisonings, by sex 0.1 per 100,000 people 2021 unchanged 143rd Suicide mortality rate, by sex 1.5 per 100,000 people 2021 down 44.4% 158th Share of deaths registered 73.26 2019 — 120th Prevalence of stunting, height for age 15.3% 2017 down 19.5% 59th Affordability - percentage of GDP per capita required to purchase 4.3 2022 up 55.8% 80th Japanese encephalitis - number of reported cases 0 2025 — 19th Deaths and missing persons due to natural disasters 2.48 2022 up 108.4% 46th Mean systolic blood pressure 120.5 2009 down 0.1% 160th Mean fasting blood glucose (mmol/l) 5 2009 down 3.8% 156th Number of pregnant women living with HIV who received antiretrovirals 1 2025 — 111th Number of new leprosy cases with G2D among children 0 2024 — 35th Neonates protected at birth against neonatal tetanus (PAB) 99.0% 2022 up 4.2% 4th Prevalence of overweight, weight for height 4.9% 2017 down 21.0% 42nd Most sold brand of cigarettes - price in currency reported 100 2020 up 426.3% 72nd Most sold brand of cigarettes - taxes as a % of price - total tax 0.7% 2020 up 106.2% 71st Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.0% 2020 — 109th Most sold brand of cigarettes - taxes as a % of price - import duties 0.6% 2020 up 87.5% 1st Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 41st Most sold brand of cigarettes - taxes as a % of price - value added 0.1% 2020 — 146th Most sold brand of cigarettes - taxes as a % of price - specific 0.0% 2020 — 128th Most sold brand of cigarettes - price in US$ at official exchange 6.49 2020 up 338.5% 35th Number healthy diet unaffordable 0 2024 — 138th Import of environmentally sound technologies 185.02 million 2019 up 189.8% 124th Most sold brand of cigarettes - price in PPP$ 11.96 2020 up 347.9% 20th Export of environmentally sound technologies 24,438 2019 up 873.6% 166th Proportion of births delivered in a health facility (Facility births) 94.5% 2017 down 2.4% 75th Number of non-autochthonous leprosy cases 0 2024 down 100.0% 47th Prevalence of wasting, weight for height, female 8.1% 2017 down 23.6% 14th Prevalence of wasting, weight for height, male 10.1% 2017 down 5.6% 14th Population with basic handwashing facilities at home 95.0% 2021 unchanged 17th Prevalence of severe wasting, weight for height, female 1.8% 2017 down 30.8% 18th Prevalence of severe wasting, weight for height, male 2.2% 2017 down 21.4% 18th Prevalence of overweight, weight for height, female 3.0% 2017 down 50.0% 59th Prevalence of overweight, weight for height, male 6.7% 2017 up 4.7% 28th HPV immunization coverage estimates among primary target cohort (9-14) 84.0% 2025 down 6.7% 31st ← Previous Page 16 of 18 Next →